Citius shareholders elect seven directors, ratify auditor at 2026 annual meeting

Citius Pharmaceuticals, Inc.

All seven director nominees elected: Mazur, Holubiak, Dutia, Holuka, McGrath, Smith, Webb.
Broker non-votes of ~6.66M shares on each director; no broker non-votes on auditor ratification.
Ratification of Wolf & Company as auditor: 8,593,946 for, 855,866 against, 673,867 abstain.
Directors serve one-year term expiring at 2027 annual meeting or until successors qualified.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.